Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer

A. Tutt, M. Robson, J. E. Garber, S. Domchek, M. W. Audeh, J. N. Weitzel, M. Friedlander, J. Carmichael

Research output: Contribution to journal › Meeting abstract

Original language	English
Journal	Journal of Clinical Oncology
Volume	27
Issue number	18
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8317ebd9be804f97a9ba957f312422e9,

title = "Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer",

author = "A. Tutt and M. Robson and Garber, {J. E.} and S. Domchek and Audeh, {M. W.} and Weitzel, {J. N.} and M. Friedlander and J. Carmichael",

year = "2009",

language = "English",

volume = "27",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "American Society of Clinical Oncology",

number = "18",

}

TY - JOUR

T1 - Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer

AU - Tutt, A.

AU - Robson, M.

AU - Garber, J. E.

AU - Domchek, S.

AU - Audeh, M. W.

AU - Weitzel, J. N.

AU - Friedlander, M.

AU - Carmichael, J.

PY - 2009

Y1 - 2009

M3 - Meeting abstract

SN - 1527-7755

VL - 27

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -